Keyphrases
Platelet-derived Growth Factor Receptor (PDGFR)
100%
NF-κB Pathway
100%
Lung Tumorigenesis
100%
Multiple Components
100%
MiR-125b
100%
MiR-23a
100%
Non-small Cell Lung Cancer (NSCLC)
50%
MicroRNA
33%
NSCLC Cells
33%
Lung Adenocarcinoma
16%
Inverse Correlation
16%
Tumorigenesis
16%
Tumor Growth
16%
Mouse Model
16%
Invasiveness
16%
Worse Prognosis
16%
ERK2
16%
RAF1
16%
Drug Sensitivity
16%
Grb2
16%
Forced Expression
16%
AKT2
16%
Therapeutic Tool
16%
Highly Aggressive
16%
Circulating Tumor Cells
16%
In Vivo Delivery
16%
PDGFR Signaling
16%
IQGAP1
16%
SOS1
16%
Patient-derived Explants
16%
NF-kB p65
16%
Immunology and Microbiology
Explant
100%
Drug Sensitivity
100%
Mouse Model
100%
P53
100%
Platelet Derived Growth Factor
100%
Circulating Tumor Cell
100%
Biochemistry, Genetics and Molecular Biology
Carcinogenesis
100%
KRAS
100%
MicroRNA
66%
Tumor Progression
33%
Mouse Model
33%
P53
33%
Drug Sensitivity
33%
Explant
33%
Platelet-Derived Growth Factor Receptor
33%
IQGAP1
33%
GRB2
33%
SOS1
33%
Protein Kinase B Beta
33%
Pharmacology, Toxicology and Pharmaceutical Science
Carcinogenesis
100%
microRNA
66%
Tumor Growth
33%
Mouse Model
33%
Receptor
33%
Protein P53
33%
Lung Adenocarcinoma
33%
Mitogen Activated Protein Kinase 1
33%
Platelet Derived Growth Factor Receptor
33%
Protein Kinase B Beta
33%